Product/Service
Sustaining Clinical Trial Disclosure
•Event Brochure: Sustaining Clinical Trial Disclosure
Date(s) And Time(s):
Nov 8 2010 8:00AM - Nov 10 2010 3:00PM
Location:
DoubleTree Hotel and Executive Meeting Center
8120 Wisconsin Avenue
Bethesda, MD 20814
Interest Area(s):
Clinical Data Management/ eClinical,Clinical Research,Medical Communications,Medical Writing,Outsourcing,Public Policy/Law/Corp. Compliance,Regulatory Affairs,Statistics
Overview:
Preconference Workshop: November 8, 2010
(Preregistration required)
Sustaining Clinical Trial Transparency: The Role and Potential Impact of HL7 CTR&R
Please note that lunch is not served on the preconference workshop day.
Conference: November 9-10, 2010
Interact with Speakers from Industry, Patient Organizations, and Government Agencies to Explore Global Perspectives on the Complexities of Clinical Trial Disclosure.
Stay informed on clinical trial disclosure global "climate changes" and hear from government abd industry experts on what this means to you. This conference will focus on "energy efficiency" and "recycling" of trial information, engage in interactive discussions with biopharmaceutical, medical device, and data standards experts on Health Level Seven (HL7) and other initiatives that will enhance your understanding of the disclosure process.
Featured Topics
- Clinical trial disclosure global "climate changes"
- Sustainability: What does the HL7 Clinical Trial Registration and Results (CTR&R) Standard mean to the future of Clinical Trial Disclosure?
- Separating "Paper/Plastics/Metals": How sponsors from pharma, biotech, medical device companies, and academia are approaching disclosure requirements
- Know your consumer: How various audiences are "reusing" your clinical trial data
- Tools to help you "conserve" resources and improve your disclosure workflow processes
- Methods for "recycling" your clinical trials data by "salvaging" existing information to populate multiple registries/results databases
- How clinical trial transparency may improve the health care environment
Learning Objectives:
At the conclusion of this conference, participants should be able to:
- Recognize how companies and research institutions are refining processes to gain efficiencies of disclosure activities
- Describe the impact and applicability of HL7 CTR&R to the overall disclosure process
- Identify similarities and differences among global regulations
- Discuss how various audiences are consuming clinical trial data
Target Audience:
Any organization that is a sponsor of a clinical trial, whether industry or investigator-sponsored, and professionals from the biopharmaceutical and medical device industries, academia, and government affected by clinical trial registration and results disclosure requirements, including:
- Clinical trial managers/staff
- Medical communications groups
- Scientific publication/medical writing groups
- Academic clinical investigators/independent investigators/study coordinators
- Statisticians
- Regulatory affairs professionals
- Quality assurance professionals
- Health policy professionals
•Event Brochure: Sustaining Clinical Trial Disclosure
- Ask a question.
- Request more detailed information or literature.
- Discuss your current project/application.
- Request a quote.
- Locate a distributor in your area.
- Schedule a demo.
